Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acris Antibodies is a life science research tools company focused on supplying antibodies and related reagents for research, diagnostic, and biopharmaceutical customers. The business originated in Germany and built a large catalog of primary antibodies, secondary antibodies, proteins, lysates, ELISA kits, and custom antibody-related services. Acris developed an online database to help researchers identify suitable antibodies for specific applications and expanded internationally, including operations in the United States. In October 2015, Acris Antibodies GmbH was acquired by OriGene Technologies, and the Acris portfolio appears to have been integrated into OriGene's broader proteomics and antibody offerings while maintaining commercial operations in Herford, Germany. The company is therefore best characterized as a commercial research reagent brand/business within the OriGene organization rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acris Antibodies.